Cargando…
Treatment of Retinoblastoma: What Is the Latest and What Is the Future
The management of retinoblastoma, the most common intraocular malignancy in children, has changed drastically over the last decade. Landmark developments in local drug delivery, namely, safer techniques for intravitreal chemotherapy injection and ophthalmic artery chemosurgery, have resulted in eye...
Autores principales: | Schaiquevich, Paula, Francis, Jasmine H., Cancela, María Belén, Carcaboso, Angel Montero, Chantada, Guillermo L., Abramson, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010858/ https://www.ncbi.nlm.nih.gov/pubmed/35433448 http://dx.doi.org/10.3389/fonc.2022.822330 |
Ejemplares similares
-
Twenty-Year Collaboration Between North American and South American Retinoblastoma Programs
por: Chantada, Guillermo L., et al.
Publicado: (2016) -
Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells
por: Winter, Ursula, et al.
Publicado: (2016) -
Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration
por: Winter, Ursula, et al.
Publicado: (2019) -
Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma
por: Aschero, Rosario, et al.
Publicado: (2021) -
Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model
por: Requejo, Flavio, et al.
Publicado: (2023)